Cardinal Health Inc. (CAH)
Cardinal Health lifts 2025 profit outlook on strong demand for costly specialty drugs
Cardinal Health raised its 2025 profit forecast on Wednesday betting on strong demand for branded and specialty medicines at its pharmaceuticals unit.
Cardinal Health's stock up 5% after earnings beat and raised guidance
Cardinal Health Inc.'s stock CAH, +1.91% rose 5% early Wednesday, after the drug distributor and medical products maker beat estimates for the second quarter and raised its guidance. Dublin, Ohio-based Cardinal Health had net income of $235 million, or 96 cents a share, for the quarter, after a loss of $56 million, or 22 cents a share, in the year-earlier period.
Cardinal Health Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Cardinal Health, Inc. CAH is set to release earnings results for its fourth quarter, before the opening bell on Aug. 14, 2024.
Here's Why Cardinal Health (CAH) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Reasons to Retain Cardinal Health (CAH) in Your Portfolio Now
Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
What's in Store for Cardinal Health (CAH) in Q4 Earnings?
Cardinal Health's (CAH) fourth-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
How To Earn $500 A Month From Cardinal Health Stock Ahead Of Q4 Earnings
Cardinal Health, Inc. CAH expects to release earnings results for its fourth quarter, before the opening bell on Wednesday, Aug. 14.
Seeking Clues to Cardinal (CAH) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
Beyond analysts' top -and-bottom-line estimates for Cardinal (CAH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.
Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Cardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cardinal Health (CAH) Beats Stock Market Upswing: What Investors Need to Know
Cardinal Health (CAH) closed at $99.52 in the latest trading session, marking a +1.18% move from the prior day.
Cardinal Health: Growth Headwinds Ahead
Cardinal Health's recent dividend raise (about 1%) reflects growth pressure ahead. With a ~13x P/E, valuation seems reasonable on the surface. However, when adjusted for growth, the current valuation points to an unfavorable return profile.
Cardinal Health (CAH) Rises But Trails Market: What Investors Should Know
Cardinal Health (CAH) reachead $100.83 at the closing of the latest trading day, reflecting a +0.57% change compared to its last close.
